RACB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RACB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Research Alliance II's sale of business for the three months ended in Sep. 2022 was $0.00 Mil. It means Research Alliance II gained $0.00 Mil from selling business. Research Alliance II's sale of business for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00 Mil.
Compared with last quarter ($0.00 Mil in Jun. 2022 ), Research Alliance II gained the same money from selling business in Sep. 2022 ($0.00 Mil).
The historical data trend for Research Alliance II's Sale Of Business can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Research Alliance II Annual Data | |||||
Trend | Dec20 | Dec21 | |||
Sale Of Business | - | - |
Research Alliance II Quarterly Data | ||||||||
Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | |
Sale Of Business | Get a 7-Day Free Trial | - | - | - | - | - |
The amount earned to sell business.
Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Research Alliance II's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.
Saba Capital Management, L.p. | 10 percent owner | 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174 |
Boaz Weinstein | 10 percent owner | 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174 |
Peter Kolchinsky | director, officer: Chief Executive Officer | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Stephen J Hoffman | director | C/O SKYLINE VENTURES, 525 UNIVERSITY AVE., SUITE 1350, PALO ALTO CA 94301 |
Thomas Leggett | director | C/O AXCELLA HEALTH INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139 |
Matthew Hammond | director, officer: Chief Investment Officer | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Research Alliance Holdings Ii Llc | 10 percent owner | 200 BERKELEY STREET 18TH FLOOR, BOSTON MA 02116 |
Theresa Cameron | director, 10 percent owner, officer: Chief Financial Officer | C/O THERAPEUTICS ACQUISITION CORP., 200 BERKELEY STREET. 18TH F L, BOSTON MA 02116 |
Clive Patience | director | C/O RESEARCH ALLIANCE CORP. II, 3172 NORTH RAINBOW BLVD. SUITE 1278, LAS VEGAS NV 89108 |
From GuruFocus
By Business Wire Business Wire • 11-28-2022
By Business Wire Business Wire • 04-28-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.